Q1: no disruption to GrandVision deal
20/05/20 -"As expected, HAL’s NAV was hit by the market turmoil experienced since the end of February. Although the share prices of HAL’s listed assets drove this decrease, the health crisis impact ..."
Pages
52
Language
English
Published on
20/05/20
You may also be interested by these reports :
14/09/26
From bad to worse, the sector has jumped from one regulatory headwind to another during the last couple of years. Now that Edenred is roughly 50% up ...
14/09/26
We keep a Buy on Pluxee as Brazilian PAT is priced in and, unlike Edenred, there is no antitrust file. However, we remain cautious on the turnaround, ...
14/09/26
We upgrade our recommendation on Edenred from Reduce to Add as we believe most of the regulatory constraints are behind. Our €35 TP rests on a ...
10/09/26
sino AG has published good results again for Q3 26 (April-June 2026), underpinned by strong trading activity and commercial gains on the back of a ...